Setria , a unique tri-peptide form of glutathione, has a molecular structure that effectively increases glutathione blood levels when taken orally
Initial dosing typically begins at the lower end of an established range to assess tolerability, with provider-directed adjustment where applicable based on response and side-effect profile
This science-backed method revolves around activating key arousal pathways with an FDA-approved peptide: PT-141 (bremelanotide), commonly known as the "Pink Shot." It addresses hypoactive sexual desire disorder (HSDD) by stimulating brain receptors involved in sexual motivation, leading to increased desire, better lubrication, heightened sensitivity, reduced pain during intercourse, and greater overall satisfactionwithout directly altering hormones.[1][2][3] Clinical trials show it can significantly improve sexual function scores in premenopausal women with HSDD, with up to 51% reporting enhanced desire compared to placebo groups, but its benefits extend to perimenopausal and postmenopausal women dealing with vaginal atrophy and low libido.[1] Weve long known that peptides can influence sexual health, but PT-141 stands out as the first FDA-approved injectable specifically for HSDD in women
This means that it works by mimicking the action of both the GLP-1 and GIP hormones, which help regulate your metabolism
Energy Expenditure and Thermogenesis The glucagon component opens the door to research on basal metabolic rate, brown adipose tissue activation, and thermogenic signaling
